MedPath

Disal

Disal® (furosemide tablets)

Approved
Approval ID

e9c22b8d-81a4-4c4d-bb39-8f37256c5b7b

Product Type

PRESCRIPTION ANIMAL DRUG LABEL

Effective Date

Apr 29, 2025

Manufacturers
FDA

Boehringer Ingelheim Animal Health USA Inc.

DUNS: 007134091

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Furosemide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0010-6739
Application NumberNADA129034
Product Classification
M
Marketing Category
C73593
G
Generic Name
Furosemide
Product Specifications
Route of AdministrationORAL
Effective DateApril 29, 2025
FDA Product Classification

INGREDIENTS (6)

FUROSEMIDEActive
Quantity: 50 mg in 1 1
Code: 7LXU5N7ZO5
Classification: ACTIB
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

Furosemide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0010-6738
Application NumberNADA129034
Product Classification
M
Marketing Category
C73593
G
Generic Name
Furosemide
Product Specifications
Route of AdministrationORAL
Effective DateApril 29, 2025
FDA Product Classification

INGREDIENTS (6)

FUROSEMIDEActive
Quantity: 12.5 mg in 1 1
Code: 7LXU5N7ZO5
Classification: ACTIB
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Disal - FDA Drug Approval Details